- Home
- EXEL vs TMQ Comparison
EXEL vs TMQ Comparison
Compare EXEL & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- TMQ
- Stock Information
- Founded
- EXEL 1994
- TMQ 2004
- Country
- EXEL United States
- TMQ Canada
- Employees
- EXEL N/A
- TMQ N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- TMQ Precious Metals
- Sector
- EXEL Health Care
- TMQ Basic Materials
- Exchange
- EXEL Nasdaq
- TMQ Nasdaq
- Market Cap
- EXEL 11.3B
- TMQ 226.7M
- IPO Year
- EXEL 2000
- TMQ N/A
- Fundamental
- Price
- EXEL $44.86
- TMQ $1.70
- Analyst Decision
- EXEL Buy
- TMQ
- Analyst Count
- EXEL 18
- TMQ 0
- Target Price
- EXEL $43.65
- TMQ N/A
- AVG Volume (30 Days)
- EXEL 3.7M
- TMQ 464.8K
- Earning Date
- EXEL 08-05-2025
- TMQ 07-10-2025
- Dividend Yield
- EXEL N/A
- TMQ N/A
- EPS Growth
- EXEL 237.58
- TMQ N/A
- EPS
- EXEL 2.20
- TMQ N/A
- Revenue
- EXEL $2,298,922,000.00
- TMQ N/A
- Revenue This Year
- EXEL $9.37
- TMQ N/A
- Revenue Next Year
- EXEL $11.05
- TMQ N/A
- P/E Ratio
- EXEL $20.33
- TMQ N/A
- Revenue Growth
- EXEL 24.49
- TMQ N/A
- 52 Week Low
- EXEL $22.13
- TMQ $0.47
- 52 Week High
- EXEL $49.62
- TMQ $2.09
- Technical
- Relative Strength Index (RSI)
- EXEL 56.79
- TMQ 71.17
- Support Level
- EXEL $43.21
- TMQ $1.30
- Resistance Level
- EXEL $48.74
- TMQ $1.74
- Average True Range (ATR)
- EXEL 2.01
- TMQ 0.10
- MACD
- EXEL 0.05
- TMQ 0.04
- Stochastic Oscillator
- EXEL 31.61
- TMQ 90.91
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.